home / stock / fate / fate short
Short Information | Fate Therapeutics Inc. (NASDAQ:FATE)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,230,753 |
Total Actual Volume | 40,508,200 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 361,538 |
Average Short Percentage | 17.96% |
Is there a FATE Short Squeeze or Breakout about to happen?
See the FATE Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-20-2025 | $1.26 | $1.19 | $1.28 | $1.16 | 1,996,286 | 285,848 | 14.32% |
06-18-2025 | $1.19 | $1.21 | $1.32 | $1.16 | 1,855,975 | 229,890 | 12.39% |
06-17-2025 | $1.24 | $1.2 | $1.31 | $1.19 | 1,519,089 | 254,951 | 16.78% |
06-16-2025 | $1.29 | $1.24 | $1.33 | $1.2126 | 1,495,197 | 288,125 | 19.27% |
06-13-2025 | $1.4 | $1.275 | $1.4 | $1.27 | 2,429,143 | 664,146 | 27.34% |
06-12-2025 | $1.5 | $1.4 | $1.5064 | $1.39 | 2,173,356 | 430,133 | 19.79% |
06-11-2025 | $1.72 | $1.55 | $1.74 | $1.5201 | 4,034,960 | 823,649 | 20.41% |
06-10-2025 | $1.55 | $1.67 | $1.82 | $1.535 | 4,935,474 | 1,059,533 | 21.47% |
06-09-2025 | $1.66 | $1.52 | $1.66 | $1.485 | 1,422,083 | 235,917 | 16.59% |
06-06-2025 | $1.36 | $1.6 | $1.68 | $1.36 | 4,680,675 | 488,435 | 10.44% |
06-05-2025 | $1.41 | $1.34 | $1.425 | $1.34 | 799,850 | 82,133 | 10.27% |
06-04-2025 | $1.36 | $1.42 | $1.45 | $1.35 | 1,898,118 | 179,479 | 9.46% |
06-03-2025 | $1.3 | $1.36 | $1.41 | $1.24 | 1,834,222 | 296,541 | 16.17% |
06-02-2025 | $1.29 | $1.3 | $1.39 | $1.26 | 1,774,372 | 316,525 | 17.84% |
05-30-2025 | $1.31 | $1.21 | $1.325 | $1.21 | 1,332,995 | 429,180 | 32.2% |
05-29-2025 | $1.27 | $1.32 | $1.38 | $1.27 | 1,424,554 | 352,659 | 24.76% |
05-28-2025 | $1.21 | $1.27 | $1.35 | $1.19 | 1,747,853 | 276,621 | 15.83% |
05-27-2025 | $1.19 | $1.22 | $1.295 | $1.19 | 1,403,848 | 163,678 | 11.66% |
05-23-2025 | $1.16 | $1.16 | $1.21 | $1.15 | 788,583 | 150,309 | 19.06% |
05-22-2025 | $1.15 | $1.2 | $1.22 | $1.14 | 961,567 | 223,001 | 23.19% |
News, Short Squeeze, Breakout and More Instantly...
Fate Therapeutics Inc. Company Name:
FATE Stock Symbol:
NASDAQ Market:
-4.13% G/L:
$1.19 Last:
1,996,286 Volume:
$1.26 Open:
$1.19 Close:
Fate Therapeutics Inc. Website:
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR); first patient to reach 1-year follow-up continues in drug-free Definition of Remission in SLE (DORIS) First extrarenal SLE patie...
SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, today announced the appointment of Ma...
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to patients, today announced that c...